Surgery, Gastroenterology and Oncology
Official journal of the International Association of Surgeons, Gastroenterologists and Oncologists
|
|
Liver Transection with Clamp Crushing, Followed by Vessel Sealing, is Superior to Crushing by LigaSure in Terms of Early Local Recurrence after Hepatectomy: A Retrospective Cohort Study
Background: Liver transection consists of two elements, crushing of the liver parenchyma and sealing of the remaining tissue. We aimed to investigate the influence of the technique used for crushing liver parenchyma on clinical outcomes in patients with hepatocellular carcinoma (HCC).
Methods: We investigated data from 65 consecutive patients who underwent open hepatectomy for HCC between January 2012 and December 2018. Patients were divided into two groups based on the technique used for crushing liver parenchyma, defined as the direct LigaSure crushing group (DLC group) and clamp-crushing group (CC group).
Results: The direct LigaSure crushing method was associated with a higher rate of early local recurrence than the clamp-crushing method (DLC group vs. CC group, 31.6% vs. 11.1%, p = 0.46). A multivariable analysis revealed that estimated blood loss, liver transection method, number of tumors, and curative resection were independent risk factors associated with early local recurrence.
Conclusions: The clamp crushing method may reduce early local recurrence compared with the direct LigaSure crushing method after hepatectomy in HCC patients.
Full Text Sources:
Abstract:
Views: 3293
Methods: We investigated data from 65 consecutive patients who underwent open hepatectomy for HCC between January 2012 and December 2018. Patients were divided into two groups based on the technique used for crushing liver parenchyma, defined as the direct LigaSure crushing group (DLC group) and clamp-crushing group (CC group).
Results: The direct LigaSure crushing method was associated with a higher rate of early local recurrence than the clamp-crushing method (DLC group vs. CC group, 31.6% vs. 11.1%, p = 0.46). A multivariable analysis revealed that estimated blood loss, liver transection method, number of tumors, and curative resection were independent risk factors associated with early local recurrence.
Conclusions: The clamp crushing method may reduce early local recurrence compared with the direct LigaSure crushing method after hepatectomy in HCC patients.
Full Text Sources:
Abstract:
Views: 3293
Watch Video Articles
For Authors
Journal Subscriptions
Current Issue
Dec 2025
Supplements
Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)
e-ISSN: 2601 - 1700 (online)
ISSN-L: 2559 - 723X
Journal Abbreviation: Surg. Gastroenterol. Oncol.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
e-ISSN: 2601 - 1700 (online)
ISSN-L: 2559 - 723X
Journal Abbreviation: Surg. Gastroenterol. Oncol.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
- SCOPUS
- EBSCO
- DOI/Crossref
- Google Scholar
- SCImago
- Harvard Library
- Open Academic Journals Index (OAJI)
Open Access Statement
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Journal Metrics
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
IASGO Society News
Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.